The global CAR T-cell therapy market shows significant development in recent years. This trend is driven by the rising prevalence of cancer, advancements in treatment, and a rapid demand for successful treatment options. The market is anticipated to reach a value of several trillion dollars by the end of the decade, with a growth rate of nearly XX%